Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WD repeat domain 82 pseudogene 2 (WDR82P2, also known as WDR82C) is a genomic locus classified as a pseudogene in relation to WD repeat domain 82 (WDR82). Pseudogenes do not encode functional proteins and generally lack biological activity. WDR82 is a protein-coding gene and a regulatory component of the SET1/COMPASS histone methyltransferase complex involved in epigenetic regulation and transcriptional termination. WDR82P2 is not included in functional gene/protein catalogs and lacks evidence for any molecular function or therapeutic relevance. There may be confusion with the active WDR82 gene, but as currently described, WDR82P2 is not a molecular target and should not be considered for drug development or disease association.
None applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WD repeat domain 82 pseudogene 2 (WDR82P2).